| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | U.S. Army purchases six eBee TAC drones from EagleNXT | ||
| Fr | Johnson & Johnson declares $1.30 per share dividend for Q1 2026 | ||
| Fr | Falconedge appoints SI Capital and Fortified Securities as joint brokers | ||
| Fr | Investar completes acquisition of Wichita Falls Bancshares | ||
| Fr | Viewbix signs definitive agreement to acquire Quantum X Labs | ||
| Fr | Clear Street names American Superconductor, Magnolia Oil & Gas as top 2026 picks | ||
| Fr | ServiceTitan stock rating reiterated at Buy by Freedom Capital Markets | ||
| Fr | H.C. Wainwright downgrades Ekso Bionics stock rating to Neutral amid merger | ||
| Fr | Corcept Therapeutics stock price target lowered to $90 at H.C. Wainwright | ||
| Fr | FibroBiologics stock maintains Buy rating at H.C. Wainwright on psoriasis IND filing | ||
| Fr | Ironwood forecasts 2026 LINZESS sales to exceed $1.1 billion | ||
| Fr | Arlington Capital to sell Tex-Tech to Michelin, spin off FMI Industries | ||
| Fr | Baker Hughes completes joint venture with Cactus for surface pressure control | ||
| Fr | A2Z Cust2Mate chairman Bentsur Joseph steps down, CEO takes interim role | ||
| Fr | Nouveau Monde Graphite settles accrued interest with share issuance | ||
| Fr | Equity Bancshares completes merger with Frontier, enters Nebraska | ||
| Fr | Innocan Pharma anticipates NYSE American listing next week | ||
| Fr | Cactus completes acquisition of Baker Hughes surface pressure control unit | ||
| Fr | Alpine Income Property Trust reports record $277.7 million in 2025 investments | ||
| Fr | Guggenheim reiterates Buy rating on Axsome stock amid FDA priority review | ||
| Fr | Corcept Therapeutics stock price target cut by Canaccord on FDA setback | ||
| Fr | Costamare declares dividends on preferred and common stock | ||
| Fr | GFL Environmental announces quarterly dividend of US$0.0154 per share | ||
| Fr | SThree purchases over 400,000 shares for employee trust | ||
| Fr | HCL Technologies stock downgraded to Hold by CLSA despite price target increase |